{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:38:29Z","timestamp":1792028309557,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["DK-52121"],"award-info":[{"award-number":["DK-52121"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["DK-076690"],"award-info":[{"award-number":["DK-076690"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1053\/j.ajkd.2010.06.006","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T06:03:39Z","timestamp":1284703419000},"page":"1168-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["The Role of Endothelial Cell Injury in Thrombotic Microangiopathy"],"prefix":"10.1053","volume":"56","author":[{"given":"Ryan J.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2010.06.006_bib1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1038\/ki.2008.624","article-title":"Treatment options for HUS secondary to Escherichia coli O157:H7","volume":"112","author":"Bitzan","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2010.06.006_bib2","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1038\/ki.2008.622","article-title":"The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007","volume":"112","author":"George","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"17","key":"10.1053\/j.ajkd.2010.06.006_bib3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2010.06.006_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2010.06.006_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2010.06.006_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0092-8674(03)00803-1","article-title":"Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor","volume":"115","author":"Matsushita","year":"2003","journal-title":"Cell"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib8","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2353\/ajpath.2010.090316","article-title":"Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney","volume":"176","author":"Nakayama","year":"2010","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.006_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.0000251522.18094.d4","article-title":"Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?","volume":"49","author":"Germain","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.006_bib10","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1159\/000228078","article-title":"The importance of cellular VEGF bioactivity in the development of glomerular disease","volume":"113","author":"Foster","year":"2009","journal-title":"Nephron Exp Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.ajkd.2010.06.006_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"issue":"13","key":"10.1053\/j.ajkd.2010.06.006_bib13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.006_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.006_bib16","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1523-1755.2002.kid554.x","article-title":"Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome","volume":"62","author":"Dran","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2010.06.006_bib17","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1523-1755.2000.00422.x","article-title":"Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy","volume":"58","author":"Kim","year":"2000","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.006_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1523-1755.2001.00935.x","article-title":"Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy","volume":"60","author":"Suga","year":"2001","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.006_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","article-title":"Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension","volume":"51","author":"van den Born","year":"2008","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ajkd.2010.06.006_bib20","doi-asserted-by":"crossref","first-page":"F754","DOI":"10.1152\/ajprenal.00419.2004","article-title":"Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension","volume":"289","author":"Patterson","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/jpet.300.3.762","article-title":"Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase","volume":"300","author":"Zhou","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1053\/j.ajkd.2010.06.006_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"issue":"5-6","key":"10.1053\/j.ajkd.2010.06.006_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00062752-200309000-00003","article-title":"The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"10","author":"George","year":"2003","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0037-1614943","article-title":"Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1","volume":"79","author":"de Moerloose","year":"1998","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"issue":"8215","key":"10.1053\/j.ajkd.2010.06.006_bib28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(81)91943-7","article-title":"Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome","volume":"1","author":"Hauglustaine","year":"1981","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib29","first-page":"148","article-title":"Recurrent hemolytic uremic syndrome during oral contraception","volume":"15","author":"Hauglustaine","year":"1981","journal-title":"Clin Nephrol"},{"issue":"6 Pt 2","key":"10.1053\/j.ajkd.2010.06.006_bib30","doi-asserted-by":"crossref","first-page":"186S","DOI":"10.1016\/S0895-7061(01)02087-8","article-title":"Cardiovascular effects of estrogen","volume":"14","author":"Tolbert","year":"2001","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2010.06.006_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.intimp.2007.08.006","article-title":"Endothelial cells are a target of both complement and kinin system","volume":"8","author":"Bossi","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1053\/j.ajkd.2010.06.006_bib32","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/eji.1830211135","article-title":"The role of C5a and antibody in the release of heparan sulfate from endothelial cells","volume":"21","author":"Platt","year":"1991","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1053\/j.ajkd.2010.06.006_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"issue":"1 Pt 2","key":"10.1053\/j.ajkd.2010.06.006_bib34","first-page":"1178","article-title":"Cyclosporine inhibits prostacyclin production by cultured human endothelial cells","volume":"19","author":"Brown","year":"1987","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00007890-199103000-00030","article-title":"Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine","volume":"51","author":"Garcia-Maldonado","year":"1991","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.ajkd.2010.06.006_bib36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/00007890-199911150-00020","article-title":"Microangiopathy in kidney and simultaneous pancreas\/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement","volume":"68","author":"Burke","year":"1999","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.ajkd.2010.06.006_bib38","series-title":"Cyclosporine disrupts complement regulation on endothelial cells","author":"Goldberg","year":"2009"},{"issue":"6","key":"10.1053\/j.ajkd.2010.06.006_bib39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1600-6143.2004.00428.x","article-title":"Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination","volume":"4","author":"Fortin","year":"2004","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.006_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/1097-0142(19850101)55:1<47::AID-CNCR2820550108>3.0.CO;2-#","article-title":"Renal complications of mitomycin C therapy with special reference to the total dose","volume":"55","author":"Valavaara","year":"1985","journal-title":"Cancer"},{"issue":"12","key":"10.1053\/j.ajkd.2010.06.006_bib41","first-page":"959","article-title":"Mitomycin-induced hemolytic uremic syndrome","volume":"108","author":"Proia","year":"1984","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-119-3-199308010-00006","article-title":"Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies","volume":"119","author":"Maguire","year":"1993","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","article-title":"Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy","volume":"3","author":"Cantrell","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ajkd.2010.06.006_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of thrombotic microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"10.1053\/j.ajkd.2010.06.006_bib45","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1053\/j.ajkd.2010.06.006_bib46","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2010.06.006_bib47","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.608","article-title":"Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome","volume":"112","author":"Karmali","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1053\/j.ajkd.2010.06.006_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ajkd.2010.06.006_bib49","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2005-07-2765","article-title":"Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura","volume":"107","author":"Banno","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.ajkd.2010.06.006_bib50","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.CIR.98.3.211","article-title":"Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study","volume":"98","author":"John","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.006_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","article-title":"Anti-inflammatory and immunomodulatory effects of statins","volume":"63","author":"Blanco-Colio","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib53","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O'Driscoll","year":"1997","journal-title":"Circulation"},{"issue":"22","key":"10.1053\/j.ajkd.2010.06.006_bib54","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1053\/j.ajkd.2010.06.006_bib55","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","article-title":"Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk","volume":"94","author":"Mercuro","year":"2004","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0002-9149(98)00862-5","article-title":"Mechanism by which quinapril improves vascular function in coronary artery disease","volume":"83","author":"Koh","year":"1999","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.06.006_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2005.07.040","article-title":"Anti-inflammatory and metabolic effects of candesartan in hypertensive patients","volume":"108","author":"Koh","year":"2006","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1053\/j.ajkd.2010.06.006_bib58","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/hrt.2003.026740","article-title":"Green tea reverses endothelial dysfunction in healthy smokers","volume":"90","author":"Nagaya","year":"2004","journal-title":"Heart"},{"issue":"1 suppl","key":"10.1053\/j.ajkd.2010.06.006_bib59","doi-asserted-by":"crossref","first-page":"292S","DOI":"10.1093\/ajcn\/81.1.292S","article-title":"Polyphenols and cardiovascular disease: effects on endothelial and platelet function","volume":"81","author":"Vita","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1053\/j.ajkd.2010.06.006_bib60","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/01.CIR.103.12.1618","article-title":"Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans","volume":"103","author":"Beckman","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2010.06.006_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00392-007-0636-3","article-title":"Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome","volume":"97","author":"Yiginer","year":"2008","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.06.006_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.35.3.746","article-title":"Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension","volume":"35","author":"Butler","year":"2000","journal-title":"Hypertension"},{"issue":"23","key":"10.1053\/j.ajkd.2010.06.006_bib63","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610010395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610010395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:55:44Z","timestamp":1759456544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610010395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0272638610010395"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.006","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Endothelial Cell Injury in Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}